Drugs / BCG-Russia-I
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02447536 Comparator | Dec 2014 → Nov 2017 | — | Bandim Health Project | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG-Russia-I | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02447536 ↗ |
| Modality | Vaccine | “Mycobacterium bovis BCG live attenuated vaccine BCG-Russia-I” NCT02447536 ↗ |